iSpecimen Inc
Price
FilingsNewest: 8-K, Listing noticeSep 10 →InsidersNo open-market buys or sales.→HoldersUBS 2.1%Jane Street 1.6%Tower Research Capital LLC (TRC) 0.0%→Financing →PeersClosest companies: INBS, TWST, CELU→
From the filings
Figures
- Revenue
- $466,302last 12 months
- Net income
- −$11.4Mlast 12 months
- Operating cash flow
- −$6.5Mlast 12 months
- Cash and equivalents
- $4.4Mat the last balance sheet
- Shares outstanding
- 1.5M shareson issue